tiprankstipranks
Atossa Therapeutics (DE:YAG2)
FRANKFURT:YAG2
Holding DE:YAG2?
Track your performance easily

Atossa Therapeutics (YAG2) Ownership - Who Owns Atossa Therapeutics?

1 Followers

Atossa Therapeutics (YAG2) Ownership Overview

0.00%0.00%<0.01%99.99%
<0.01% Other Institutional Investors
― ETFs
99.99% Public Companies and
Individual Investors
The ownership structure of Atossa Therapeutics (DE:YAG2) stock is a mix of institutional, retail, and individual investors. , and 99.99% is owned by Public Companies and Individual Investors.
The ownership structure of Atossa Therapeutics (DE:YAG2) stock is a mix of institutional, retail, and individual investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Apr 11, 2024
xxxxxxxxxxxxx
$44250
Nov 17, 2023
Gregory Weaver
Former Evp, Cfo, & Director
xxxxxxxxxxxxx
$32500

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
55Insider63
9,400Insider10,754
10,000Insider11,440
17,674Insider20,219
100Insider114
4,796,858Insider5,487,606
17,682Institution22,014
5,607,189Institution6,980,950
4,208,705Institution5,239,838
4,688Institution5,837

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
28,009Institution34,871
1,119,072Institution1,393,245
45,962Institution57,223
248,228Institution309,044
5,527,330Institution6,881,526
81,493Institution101,459
98,096Institution122,130
-2,680Institution-3,337

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Atossa Therapeutics (DE:YAG2)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 99.99% is held by retail investors.
    What percentage of Atossa Therapeutics (DE:YAG2) stock is held by institutional investors?
    According to the latest TipRanks data, approximately <0.01% of Atossa Therapeutics (DE:YAG2) stock is held by institutional investors.
      What percentage of Atossa Therapeutics (DE:YAG2) stock is held by retail investors?
      According to the latest TipRanks data, approximately 99.99% of Atossa Therapeutics (DE:YAG2) stock is held by retail investors.
        Who owns the most shares of Atossa Therapeutics (DE:YAG2)?
        Gregory Weaver owns the most shares of Atossa Therapeutics (DE:YAG2).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis